Paper
RSC Advances
The mixture was reuxed for 24 h to make a Fe nano catalyst on tiny decrease in activity. The proposed methodology could be
the surface of nano scale Si/Al (Scheme 4). The formation of used in organic synthesis for the syntheses of
nano catalyst on the SiO2/Al2O3 mixed oxides was veried using arylaminotetrazoles.
BET, elemental analysis, FT-IR, UV-vis, BET, ICP, SEM, EDS,
XPS, TGA and TEM.2,3,18,19
In the present work, we have performed theoretical analyses
of tetrazole derivatives by density functional theory calculations
using the B3LYP/6-31G level. The thermodynamic parameters,
frontier molecular orbitals (HOMO and LUMO), and electronic
density (MEP) were obtained. Based on the thermodynamic
parameters we found that all molecules are stable. The presence
of the nitro group (NO2) in molecule 3a reduces the energy of
the HOMO, therefore the HOMO–LUMO energy gap of molecule
3a is the smallest (3.89 eV). The other molecular properties such
as dipole moment (m), energy of structure formation (DE; Har-
tree Fock) and point group were calculated. As shown by the
MEPs, among molecules 3a–3f, molecules 3b and 3c have the
greatest electronic density on the tetrazole ring and among 3g–
3m, molecule 3l has the greatest electronic density on the tet-
razole ring.
General procedure for the synthesis of arylaminotetrazoles
using the nano catalyst
The nano catalyst was added to a mixture of cyanamides (1a–m)
(2 mmol), sodium azide (200 mg, 3 mmol) and distilled dime-
thylformamide (6 mL) and stirred at the desired temperature for
the appropriate time (Table 4). Aer completion of the reaction
(as monitored by TLC), the catalyst was centrifuged, washed
with ethyl acetate and the centrifugate was treated with EtOAc (3
ꢂ 10 mL) and 5 N HCl (20 mL) and stirred vigorously. The
resultant organic layer was separated and the aqueous layer was
again extracted with ethyl acetate (25 mL). The combined
organic layers were washed with water, the solvent removed and
the crude solid arylaminotetrazole recrystallized (aqueous
ethanol). The pure products were characterized by IR and NMR.
The physical data (mp, IR, 1H NMR, 13C NMR) of known
compounds were found to be identical with those reported in
the literature.11–14
Acknowledgements
We thank the research council of Bu-Ali Sina and the Islamic
Azad University for nancial support.
Notes and references
Analytical data for selected compounds
5-(4-Acethylphenyl)amino-1H-tetrazole (1e, Table 4, entry 6).
1 R. J. Herr, Bioorg. Med. Chem., 2002, 10, 3379.
2 D. Habibi, A. R. Faraji, M. Arshadi and J. L. G. Fierroc, J. Mol.
Catal. A: Chem., 2013, 372, 90; M. Uyanik, M. Akakura and
K. Ishihara, J. Am. Chem. Soc., 2009, 131, 251.
3 D. Habibi and A. R. Faraji, C. R. Chim., 2013, 16, 888;
M. Uyanik and K. Ishihara, Chem. Commun., 2009, 2086;
B. Zeynizadeh and P. Lot, Asian J. Chem., 2009, 21, 3617.
4 G. F. Holland and J. N. Pereira, J. Med. Chem., 1967, 10, 149.
5 L. A. Flippin, Tetrahedron Lett., 1991, 32, 6857.
6 P. Rhonnstad and D. Wensbo, Tetrahedron Lett., 2002, 43,
3137.
1
M.p.: 215–217ꢀC; H NMR (300 MHz, DMSO-d6): 10.38 (s, 1H),
7.92 (d, J ¼ 7.95 Hz, 2H), 7.14 (d, J ¼ 7.64 Hz, 1H), 1.10 (s, 1H)
ppm; 13C NMR (75 MHz, DMSO-d6): 196.7, 145.3, 130.4, 130.1,
116.2, 31.7, 26.8; IR (KBr): ꢀn ¼ 3403, 3282, 3177, 3024, 2978,
2839, 2780, 2440, 1651, 1627, 1605, 14 579, 1470, 1426, 1364,
1285, 1258, 1195, 1055, 1024, 962, 885, 865, 835, 733, 592 cmꢁ1
;
anal. calcd for C9H5N5O: C, 53.20; H, 4.46; N, 34.47. Found: C,
53.16; H, 4.39; N, 35.12%.
1-(2,6-Dimethylphenyl)-5-amino-1H-tetrazole (1m, Table 4,
1
entry 13). M.p. 148–149ꢀC; H NMR (500 MHz, DMSO-d6): 7.02
(s, 3H), 5.19 (s, 2H), 2.27 (s, 6H) ppm; 13C NMR (125 MHz,
DMSO-d6): 157.5, 137.6, 136.6, 128.3, 126.3, 18.5 ppm; IR (KBr):
ꢀn ¼ 3430, 3295, 3070, 2955, 2920, 2854, 1654, 1600, 1579, 1535,
1477, 1440, 1376, 1349, 1260, 1217, 1160, 1114, 917, 869, 760,
700, 662, 636, 546, 516, 496 cmꢁ1; anal. calcd for C9H11N5: C,
57.12; H, 5.86; N, 37.02. Found: C, 57.45; H, 5.67; N, 36.57%.
7 E. O. John, R. L. Kirchmeier and J. M. Shreeve, Inorg. Chem.,
1989, 28, 4629.
8 N. P. Peet, L. E. Baugh, S. Sundler, J. E. Lewis,
E. H. Matthews, E. L. Olberding and D. N. Shah, J. Med.
Chem., 1968, 29, 2403.
9 W. L. Garbrecht and R. M. Herbst, J. Org. Chem., 1953, 18,
1014.
10 A. R. Modarresi-Alam and M. Nasrollahzadeh, Turk. J. Chem.,
2009, 33, 267.
Conclusions
In conclusion, a simple and convenient method has been 11 D. Habibi and M. Nasrollahzadeh, Synth. Commun., 2010, 40,
developed for the synthesis of arylaminotetrazoles in the pres- 3159.
ence of the nano catalyst as a heterogeneous reusable catalyst 12 M. Nasrollahzadeh, D. Habibi, A. R. Faraji and Y. Bayat,
under thermal conditions. Well-dispersed Fe, Mn and Co Tetrahedron, 2010, 66, 3866.
nanoparticles have been prepared on a SiO2/Al2O3 nanosized 13 D. Habibi, M. Nasrollahzadeh and Y. Bayat, Synth. Commun.,
heterogeneous support and have been successfully employed 2011, 41, 2135.
and tested in the syntheses of arylaminotetrazoles. The signif- 14 M. Nasrollahzadeh, D. Habibi, Z. Shahkarami and Y. Bayat,
icant advantages of this methodology are high yields, mild Tetrahedron, 2009, 65, 10715.
reaction conditions, elimination of dangerous and harmful 15 D. Azarifar and D. Sheikh, Synth. Commun., 2013, 43, 2517;
hydrazoic acid and a simple work-up procedure. The nano
F. Himo, Z. P. Demko, L. Noodleman and K. B. Sharpless,
catalyst can be recovered and reused by simple ltration with a
J. Am. Chem. Soc., 2002, 124, 12210.
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 47625–47636 | 47635